Search clinical trials for: Flow-cytometric analysis

Total 13283 results

Istanbul Training and Research Hospital

Completed

Immune Cell Subgroups in Covid 19 Patients

Covid19

Turkey
Istanbul Training and Research Hospital

Completed

Is Lymphocyte Subtype Important for Acute Pancreatitis Severity?

Immune System Diseases | Pancreatitis | Lymphocytic Infiltrate

Turkey
Assiut University

Unknown

New Markers for Minimal Residual Disease in Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Egypt
Istanbul Training and Research Hospital
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Completed

The Status of Immune Checkpoints at Gastrointestinal Cancer

Gastrointestinal Cancer

Turkey
Istanbul Training and Research Hospital

Completed

Immune Checkpoints in Intraabdominal Ascites Fluid

Colorectal Cancer

Turkey
Istanbul Training and Research Hospital

Completed

T Helper Cytokines in End Stage Colorectal Cancers

Colorectal Cancer

Turkey
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia

Leukemia
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

Lung Cancer | Metastatic Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

Leukemia
Charite University, Berlin, Germany
Berlin Institute of Health

Active, not recruiting

Urinary T Cell Biomarker for Prediction in Lupus Nephritis

Lupus Nephritis

Germany, United Kingdom
British Columbia Cancer Agency
National Cancer Institute (NCI)

Terminated

Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples (SAGE)

Cervical Cancer | Precancerous Condition

Canada
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia

Leukemia
Vanderbilt University
National Cancer Institute (NCI)

Terminated

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Chronic Myeloproliferative Disorders | Cancer Survivor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia

Leukemia
Assiut University

Completed

Role of Regulatory B Cells in Behçet's Disease

Behcet Disease

Egypt
GWT-TUD GmbH

Terminated

Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY (SAMBA)

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

France, Germany
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Study of Bone Marrow Samples From Patients With Acute Leukemia

Leukemia
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Neoplasms

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Terminated

Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia

Leukemia
Istanbul Training and Research Hospital

Completed

Cytokine Levels of Patients Who Underwent Obesity Surgery

Obesity

Turkey
Istanbul Training and Research Hospital

Completed

Cytokine Status of Covid-19 Patients

Covid19

Turkey
University Hospital, Grenoble

Recruiting

Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression for Ruling Out Myelodysplastic Syndromes: Protocol for a Diagnostic Accuracy Study (MPO-MDS-Valid)

Myelodysplastic Syndromes

France
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia

Leukemia
Istanbul Training and Research Hospital

Completed

The Relationship Between the Differences in Blood Cytokine Values in Breast Cancers.

Breast Cancer

Turkey
Istanbul Training and Research Hospital

Completed

Serum Cytokine Values in Patients With Granulomatous Mastitis

Granulomatous Mastitis

Turkey
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer

Kidney Cancer
Vanderbilt University Medical Center
National Cancer Institute (NCI)

Completed

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Head and Neck Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial

Leukemia
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia

Leukemia
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

Leukemia
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997

Leukemia
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Myelodysplastic/Myeloproliferative Neoplasms

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia

Leukemia
Sohag University

Not yet recruiting

Expression of Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PDL-1) in Acute Lymphoblastic Leukemia in Pediatric

Acute Lymphoblastic Leukemia in Pediatric

Egypt
Charite University, Berlin, Germany
Berlin Institute of Health

Active, not recruiting

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Glomerulonephritis Acute

United Kingdom, Germany
Istanbul Training and Research Hospital

Completed

Immune Cells in Patients With Granulomatous Mastitis

Granulomatous Mastitis

Turkey
AIDS Malignancy Consortium
National Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLC; AIDS and Cancer Specimen Resource

Terminated

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Lymphoma | Lung Cancer

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer

Breast Cancer

United States
Charite University, Berlin, Germany

Completed

Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis (PRE-FLARED)

Glomerulonephritis Acute

Germany
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

Lymphoma
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia

Leukemia
University Hospital, Montpellier

Not yet recruiting

Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma? (CARTROG)

Diffuse Large B Cell Lymphoma
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Lung Cancer

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Samples From Young Patients With Neuroblastoma

Neuroblastoma
University Hospital, Grenoble

Completed

Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes (MPO-MDS-PILOT)

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia

France
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia

Leukemia
European Working Group of MDS in Childhood

Unknown

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

Myelodysplastic Syndromes | Leukemia

Germany, Austria, Switzerland, Czech Republic, Netherlands, Denmark, Belgium, Italy, Poland
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers

Myelodysplastic Syndromes | Leukemia

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

Melanoma (Skin)

Search clinical trials for: Flow-cytometric analysis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations